Acute Decompensated Heart Failure After Initiation of Amiodarone in a Patient With Anderson-Fabry Disease
Overview
Authors
Affiliations
A 54-year-old man with the lysosomal storage disorder Anderson-Fabry disease (AFD) and cardiac involvement was placed on amiodarone for treatment of symptomatic paroxysmal atrial fibrillation. Shortly thereafter, he developed symptoms of acute decompensated heart failure, requiring hospital admission. Endomyocardial biopsy demonstrated findings consistent with AFD and possible amiodarone toxicity. Amiodarone was discontinued, and the patient's heart failure resolved with return to baseline status. Amiodarone is known to alter lysosomal pH and enzyme activity, and this case illustrates how it should be used with considerable caution in patients with AFD.
Arrhythmogenesis in Fabry Disease.
Roy A, Cumberland M, OShea C, Holmes A, Kalla M, Gehmlich K Curr Cardiol Rep. 2024; 26(6):545-560.
PMID: 38607539 PMC: 11199244. DOI: 10.1007/s11886-024-02053-2.
Vijapurapu R, Roy A, Demetriades P, Warfield A, Hughes D, Moon J Open Heart. 2023; 10(2).
PMID: 37460269 PMC: 10357684. DOI: 10.1136/openhrt-2023-002316.
Averbuch T, White J, Fine N Front Cardiovasc Med. 2023; 10:1152568.
PMID: 37332587 PMC: 10272370. DOI: 10.3389/fcvm.2023.1152568.
Pintavorn P, Munie S, Munagapati S Can J Kidney Health Dis. 2022; 9:20543581221124635.
PMID: 36325261 PMC: 9619285. DOI: 10.1177/20543581221124635.
Tsukimura T, Shiga T, Saito K, Ogawa Y, Sakuraba H, Togawa T Mol Genet Metab Rep. 2021; 28:100773.
PMID: 34136356 PMC: 8178118. DOI: 10.1016/j.ymgmr.2021.100773.